(50) have demonstrated that TP mitigates high glucose-induced epithelial-mesenchymal transition (EMT) in podocytes, a critical process in DN pathogenesis, by attenuating the activation of NLRP3 inflammatory vesicles. This evidence concerns the gene NLRP3 and liver dysplastic nodule.